Skip to content

Clarithromycin EP Impurity J

Clarithromycin EP Impurity J

Product Description
CAT No.
ALN-C040011
CAS No.
13127-18-9
Mol. F.
C37H68N2O13
Mol. Wt.
748.94
Stock
Please Inquire
Chemical Name : (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,Z)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
Smiles : C[C@H]([C@H]([C@](O)(C[C@H](/C1=N/O)C)C)O[C@@](O[C@H](C)C[C@@H]2N(C)C)([H])[C@@H]2O)[C@]([C@H](C(O[C@@H]([C@@](O)([C@H](O)[C@H]1C)C)CC)=O)C)([H])O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC
Synonym : Erythromycin A Oxime ;Roxithromycin Impurity C ;Erythromycin A (E)-9-oxime ;

Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: method scaling versus re-validation

By Makoni, Pedzisai A.; Chikukwa, Mellisa T. R.; Khamanga, Sandile M. M.; Walker, Roderick B.nFrom Scientia Pharmaceutica (2019), 87(4), 31

Stability indicating Rp-Hplc method development and validation for the simultaneous estimation of gemcitabine and clarithromycin in bulk and pharmaceutical dosage form

By Kumar, Y. Anil; Sirisha, Y.; Harini, A. L.; Prathyusha, A. – From World Journal of Pharmaceutical Research (2018), 7(8Spec.Iss.), 1-8

Request For Quotation